UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(Mark One)

 

x

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarter ended November 30, 20172019

 

OR

 

¨

TRANSACTION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______________ to _______________

 

Commission File No. 333-196663000-55965

 

GRIPEVINE INC.flooidCX Corp.

(Exact Name of Registrant as Specified in Its Charter)

 

Nevada

 

35-2511643

(State of Other Jurisdiction

of Incorporation or Organization)

 

(I.R.S. Employer

Identification Number)

 

1282A Cornwall Road

Oakville, Ontario

Canada

 

L6J 7W5

(Address of Principal Executive Offices)

 

(Zip Code)

 

(855) 474-7384535-6643

(Registrant’s Telephone Number, Including Area Code)

Copies to:

Sichenzia Ross Ference Kesner LLP

1185 Avenue of the Americas, 37th Floor

New York, NY 10036

Attn: Greg Sichenzia, Esq.,

Jay Yamamoto, Esq.

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “non-accelerated filer”, “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer

¨

Accelerated filer

¨

Non-accelerated filer

¨

Smaller reporting company

x

 

Emerging growth company

x

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. x¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

 

As of January 15, 2018,14, 2020, there were 124,720,532147,103,318 shares of our common stock issued and outstanding, par value $0.001.

 

 
 
 
 

TABLE OF CONTENTS

 

 

Page

 

Cautionary Note Concerning Forward-Looking Statements

 

3

 

PART I – FINANCIAL INFORMATION

 

Item 1.

Unaudited Interim Condensed CombinedConsolidated Financial Statements

 

4F-1

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and PlanResults of Operations

 

54

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

 

98

 

Item 4.

Controls and Procedures

 

98

 

PART II – OTHER INFORMATION

 

Item 1.

Legal Proceedings

 

109

 

Item 1A.

Risk Factors

 

109

 

Item 2.

Unregistered SaleSales of Equity Securities and Use of Proceeds

 

109

 

Item 3.

Defaults Upon Senior Securities

 

119

 

Item 4.

Mine Safety Disclosures

 

119

 

Item 5.

Other Information

 

119

 

Item 6.

Exhibits

 

1210

 

SIGNATURES

 

1311

 

 
2
 
Table of Contents

  

Cautionary Note Concerning Forward-Looking Statements

 

This Quarterly Report on Form 10-Q contains "forward -looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended.“forward-looking statements”. These forward-looking statements, including without limitation forward-looking statements made under the caption “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” involve risks and uncertainties. Any statements contained in this Quarterly Report that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements include, without limitation, statements as to our future operating results; seasonality expectations; plans for the development, utilization or disposalmarketing of manufacturing facilities;our services; future economic conditions; our expectations as to legal proceedings; the effect of our market and product development efforts; and expectations or plans relating to the implementation or realization of our strategic goals and future growth, including through potential future acquisitions. Forward-looking statements may include, among other things, statements relating to future sales, earnings, cash flow, results of operations, use of cash and other measures of financial performance, as well as statements relating to future dividend payments. Other forward-looking statements may be identified through the use of words such as “believes,” “anticipates,” “may,” “should,” “will,” “plans,” “projects,” “expects,” “expectations,” “estimates,” “predicts,” “targets,” “forecasts,” “strategy,” and other words of similar meaning in connection with the discussion of future operating or financial performance. These statements are based on current expectations, estimates and projections about the industries in which we operate, and the beliefs and assumptions made by management. Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and changes in circumstances that are difficult to predict. Accordingly, the Company’s actual results may differ materially from those contemplated by the forward-looking statements. Investors, therefore, are cautioned against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Readers should refer to the discussions under “Risk Factors” contained in our Annual Report on Form 10-K for the fiscal year ended February 28, 20172019 concerning certain factors that could cause our actual results to differ materially from the results anticipated in such forward-looking statements. These Risk Factors are hereby incorporated by reference into this Quarterly Report.

 

 

3

 
Table of Contents

PART I - FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

Interim FLOOIDCX CORP.

Condensed CombinedConsolidated Financial Statements

Gripevine, Inc.

For The Quarterly PeriodThree and Nine Months Ended November 30, 20172019 and 2018

(Expressed in U.S. dollars)

(unaudited)

 
4
Table of Contents

   

Gripevine, Inc.

Interim Condensed Combined Financial Statements

For The Quarterly Period Ended November 30, 2017 (Unaudited)

Table of contents

Interim Condensed Combined Balance Sheets

 

 

F-2

Index

 

 

 

 

Interim Condensed CombinedConsolidated Balance Sheets

F–2

Condensed Consolidated Statements of Operations and Comprehensive Loss

 

F-3F–3

 

 

 

 

Interim Condensed CombinedConsolidated Statement of Stockholders’ Deficit

F–4

Condensed Consolidated Statements of Cash Flows

 

F-4F–6

 

 

 

 

Notes to Interimthe Condensed CombinedConsolidated Financial Statements

 

F-5F–7

 

 

 
F-1
 
Table of Contents

 

Gripevine, Inc.

INTERIM CONDENSED COMBINED BALANCE SHEETS

AS AT NOVEMBER 30, 2017 (UNAUDITED) AND FEBRUARY 28, 2017 (AUDITED)

(Expressed in US dollars)

FLOOIDCX CORP.

Condensed Consolidated Balance Sheets

(Expressed in U.S. dollars)

(unaudited)

 

 

 

As at

November 30,

2017

 

 

As at

February 28,

2017

 

 

 

$

 

 

$

 

CURRENT ASSETS

 

 

 

 

 

 

Cash

 

 

153,082

 

 

 

32,678

 

Prepaid and other receivables

 

 

31,791

 

 

 

20,281

 

Total current assets

 

 

184,873

 

 

 

52,959

 

 

 

 

 

 

 

 

 

 

Equipment [Note 5]

 

 

37,009

 

 

 

41,655

 

TOTAL ASSETS

 

 

221,882

 

 

 

94,614

 

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES

 

 

 

 

 

 

 

 

Accounts payable

 

 

26,683

 

 

 

22,325

 

Accrued liabilities

 

 

28,083

 

 

 

78,827

 

Loans payable [Note 6]

 

 

2,046,526

 

 

 

1,822,953

 

Due to related parties [Note 6]

 

 

174,904

 

 

 

178,906

 

Due to a shareholder [Note 6]

 

 

654,357

 

 

 

568,547

 

TOTAL LIABILITIES

 

 

2,930,553

 

 

 

2,671,558

 

 

 

 

 

 

 

 

 

 

STOCKHOLDERS' DEFICIENCY

 

 

 

 

 

 

 

 

Preferred stock, $0.001 par value, 20,000,000 authorized. 1,000,000 shares issued and outstanding as at November 30, 2017 and February 28, 2017 [Note 7]

 

 

1,000

 

 

 

1,000

 

Common stock, $0.001 par value, 300,000,000 authorized, 124,720,532 and 120,000,000 shares issued and outstanding as at November 30, 2017 and February 28, 2017, respectively [Note 7]

 

 

124,721

 

 

 

120,000

 

Common stock to be issued [Note 7]

 

 

3,022

 

 

 

5,249

 

Additional paid-in-capital

 

 

45,313,192

 

 

 

43,698,125

 

Accumulated other comprehensive income

 

 

129,346

 

 

 

233,651

 

Accumulated deficit

 

 

(48,279,952)

 

 

(46,634,969)

Total stockholders' deficiency

 

 

(2,708,671)

 

 

(2,576,944)

TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY

 

 

221,882

 

 

 

94,614

 

 

 

 

 

 

 

 

 

 

Commitments [Note 9]

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Subsequent events [Note 10]

 

 

 

 

 

 

 

 

 

 

November 30,

2019

$

 

 

February 28,

2019

$

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

Cash

 

 

90,709

 

 

 

5,517

 

Prepaid expenses and deposits

 

 

9,389

 

 

 

18,458

 

Total Current Assets

 

 

100,098

 

 

 

23,975

 

Property and equipment (Note 3)

 

 

20,285

 

 

 

25,009

 

Total Assets

 

 

120,383

 

 

 

48,984

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS’ DEFICIT

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Current Liabilities

 

 

 

 

 

 

 

 

Accounts payable and accrued liabilities

 

 

128,868

 

 

 

121,300

 

Deferred revenue

 

 

15,000

 

 

 

 

Loans payable (Note 4)

 

 

2,694,314

 

 

 

2,526,650

 

Due to related party (Note 5)

 

 

738,994

 

 

 

633,060

 

Total Liabilities

 

 

3,577,176

 

 

 

3,281,010

 

 

 

 

 

 

 

 

 

 

Nature of Operations and Continuance of Business (Note 1)

 

 

 

 

 

 

 

 

Commitments (Note 9)

 

 

 

 

 

 

 

 

Subsequent Event (Note 10)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ Deficit

 

 

 

 

 

 

 

 

Preferred stock, 20,000,000 shares authorized, $0.001 par value 1,000,000 shares issued and outstanding

 

 

1,000

 

 

 

1,000

 

Common stock, 300,000,000 shares authorized, $0.001 par value 147,103,318 and 136,603,318 shares issued and outstanding, respectively

 

 

147,103

 

 

 

136,353

 

Common stock issuable

 

 

10,000

 

 

 

10,000

 

Additional paid-in capital

 

 

50,284,331

 

 

 

48,250,116

 

Accumulated other comprehensive income

 

 

249,935

 

 

 

255,023

 

Deficit

 

 

(54,149,162)

 

 

(51,884,518)

Total Stockholders’ Deficit

 

 

(3,456,793)

 

 

(3,232,026)

Total Liabilities and Stockholders’ Deficit

 

 

120,383

 

 

 

48,984

 

 

See(The accompanying notes to interimare an integral part of these condensed combinedconsolidated financial statementsstatements)

 

 
F-2
 
Table of Contents

 

Gripevine, Inc.

INTERIM CONDENSED COMBINED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

FOR THE THREE AND NINE MONTHS ENDED NOVEMBER 30, 2017 AND 2016 (UNAUDITED)

(Expressed in US dollars)

FLOOIDCX CORP.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(Expressed in U.S. dollars)

(unaudited)

 

 

 

For the

Three Months

Ended

November 30,

2017

 

 

For the

Three Months

Ended

November 30,

2016

 

 

For the

Nine Months

Ended

November 30,

2017

 

 

For the

Nine Months

Ended

November 30,

2016

 

 

 

$

 

 

$

 

 

$

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

REVENUE

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock based compensation [Note 7]

 

 

155,429

 

 

 

9,673,604

 

 

 

744,399

 

 

 

29,020,811

 

Research and development expenses [Note 8]

 

 

146,684

 

 

 

318,430

 

 

 

599,766

 

 

 

778,582

 

General and administrative expenses

 

 

118,262

 

 

 

77,895

 

 

 

300,818

 

 

 

290,323

 

TOTAL OPERATING EXPENSES

 

 

420,375

 

 

 

10,069,929

 

 

 

1,644,983

 

 

 

30,089,716

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income taxes

 

 

 

 

 

 

 

 

 

 

 

 

NET LOSS

 

 

420,375

 

 

 

10,069,929

 

 

 

1,644,983

 

 

 

30,089,716

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Translation adjustment

 

 

79,679

 

 

 

(21,478)

 

 

(104,305)

 

 

(18,539)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

COMPREHENSIVE LOSS

 

 

500,054

 

 

 

10,048,451

 

 

 

1,540,678

 

 

 

30,071,177

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LOSS PER SHARE, BASIC AND DILUTED

 

 

0.004

 

 

 

0.084

 

 

 

0.013

 

 

 

0.251

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING

 

 

122,749,321

 

 

 

120,000,000

 

 

 

120,909,775

 

 

 

120,000,000

 

 

 

Three Months
Ended

November 30,

2019

$

 

 

Three Months
Ended

November 30,

2018

$

 

 

Nine Months

Ended

November 30,

2019

$

 

 

Nine Months
Ended

November 30,

2018

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expenses

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative (Note 5)

 

 

346,650

 

 

 

117,636

 

 

 

730,209

 

 

 

385,863

 

Research and development (Note 5)

 

 

316,078

 

 

 

158,640

 

 

 

1,485,435

 

 

 

795,664

 

Total expenses

 

 

658,728

 

 

 

276,276

 

 

 

2,215,644

 

 

 

1,181,527

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss before other expense

 

 

(658,728)

 

 

(276,276)

 

 

(2,215,644)

 

 

(1,181,527)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss on settlement of debt (Note 6)

 

 

(49,000)

 

 

 

 

 

(49,000)

 

 

 

Net loss for the period

 

 

(707,728)

 

 

(276,276)

 

 

(2,264,644)

 

 

(1,181,527)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other comprehensive loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation loss

 

 

(3,100)

 

 

(55,688)

 

 

(5,088)

 

 

(107,932)

Comprehensive loss for the period

 

 

(710,828)

 

 

(331,964)

 

 

(2,269,732)

 

 

(1,289,459)

Net loss per share, basic and diluted

 

 

(0.01)

 

 

 

 

 

(0.02)

 

 

(0.01)

Weighted average number of shares outstanding

 

 

140,213,208

 

 

 

136,353,318

 

 

 

137,685,136

 

 

 

134,776,302

 

 

See(The accompanying notes to interimare an integral part of these condensed combinedconsolidated financial statementsstatements)

 

 
F-3
 
Table of Contents

 

Gripevine, Inc.

INTERIM CONDENSED COMBINED STATEMENTS OF CASH FLOWS

FOR THE NINE MONTHS ENDED NOVEMBER 30, 2017 AND 2016 (UNAUDITED)

(Expressed in US dollars)

FLOOIDCX CORP.

Condensed Consolidated Statements of Stockholders’ Deficit

(Expressed in U.S. dollars)

(unaudited)

 

 

 

For the Nine

Months

Ended

November 30,

2017

 

 

For the Nine

Months

Ended

November 30,

2016

 

 

 

$

 

 

$

 

 

 

 

 

 

 

 

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

 

Net loss

 

 

(1,644,983)

 

 

(30,089,716)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Stock based compensation

 

 

744,399

 

 

 

29,020,811

 

Depreciation

 

 

17,780

 

 

 

7,963

 

 

 

 

 

 

 

 

 

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Prepaid expenses and other receivables

 

 

(11,105)

 

 

(2,641)

Accounts payable

 

 

3,836

 

 

 

20,841

 

Accrued liabilities

 

 

(52,678)

 

 

(3,824)

Net cash used in operating activities

 

 

(942,751)

 

 

(1,046,566)

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

 

 

 

 

 

 

Purchase of equipment

 

 

(11,998)

 

 

(14,486)

Net cash used in investing activities

 

 

(11,998)

 

 

(14,486)

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

 

 

 

 

Proceeds from issuance of shares

 

 

873,163

 

 

 

 

Loans payable

 

 

166,687

 

 

 

951,666

 

Due to related parties

 

 

(8,961)

 

 

(47,034)

Due to a shareholder

 

 

69,552

 

 

 

159,792

 

Net cash provided by financing activities

 

 

1,100,441

 

 

 

1,064,424

 

 

 

 

 

 

 

 

 

 

Net increase in cash during the period

 

 

145,692

 

 

 

3,372

 

 

 

 

 

 

 

 

 

 

Effect of foreign currency translation

 

 

(25,288)

 

 

(1,575)

 

 

 

 

 

 

 

 

 

Cash, beginning of period

 

 

32,678

 

 

 

23,926

 

Cash, end of period

 

 

153,082

 

 

 

25,723

 

 

 

Preferred Stock

 

 

Common Stock

 

 

Common Stock

 

 

Additional

Paid-in

 

 

Accumulated

Other Comprehensive

 

 

 

 

Total

Stockholders’

 

 

 

Shares

#

 

 

Amount

$

 

 

Shares

#

 

 

Amount

$

 

 

Issuable

$

 

 

Capital

$

 

 

Income

$

 

 

Deficit

$

 

 

Deficit

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, February 28, 2019

 

 

1,000,000

 

 

 

1,000

 

 

 

136,353,318

 

 

 

136,353

 

 

 

10,000

 

 

 

48,250,116

 

 

 

255,023

 

 

 

(51,884,518)

 

 

(3,232,026)

Fair value of stock options granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

868,879

 

 

 

 

 

 

 

 

 

868,879

 

Foreign exchange translation gain

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

56,671

 

 

 

 

 

 

56,671

 

Net loss for the period

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,086,256)

 

 

(1,086,256)

Balance, May 31, 2019

 

 

1,000,000

 

 

 

1,000

 

 

 

136,353,318

 

 

 

136,353

 

 

 

10,000

 

 

 

49,118,995

 

 

 

311,694

 

 

 

(52,970,774)

 

 

(3,392,732)

Shares issued for cash

 

 

 

 

 

 

 

 

250,000

 

 

 

250

 

 

 

 

 

 

49,750

 

 

 

 

 

 

 

 

 

50,000

 

Fair value of stock options granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

255,482

 

 

 

 

 

 

 

 

 

255,482

 

Foreign exchange translation loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(58,659)

 

 

 

 

 

(58,659)

Net loss for the period

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(470,660)

 

 

(470,660)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, August 31, 2019

 

 

1,000,000

 

 

 

1,000

 

 

 

136,603,318

 

 

 

136,603

 

 

 

10,000

 

 

 

49,424,227

 

 

 

253,035

 

 

 

(53,441,434)

 

 

(3,616,569)

Shares issued for cash

 

 

 

 

 

 

 

 

4,500,000

 

 

 

4,500

 

 

 

 

 

 

220,500

 

 

 

 

 

 

 

 

 

225,000

 

Fair value of shares issued pursuant to settlement of loans payable

 

 

 

 

 

 

 

 

3,500,000

 

 

 

3,500

 

 

 

 

 

 

220,500

 

 

 

 

 

 

 

 

 

224,000

 

Fair value of shares issued for services

 

 

 

 

 

 

 

 

2,500,000

 

 

 

2,500

 

 

 

 

 

 

170,000

 

 

 

 

 

 

 

 

 

172,500

 

Fair value of stock options granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

249,104

 

 

 

 

 

 

 

 

 

249,104

 

Foreign exchange translation loss

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(3,100)

 

 

 

 

 

(3,100)

Net loss for the period

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(707,728)

 

 

(707,728)

Balance, November 30, 2019

 

 

1,000,000

 

 

 

1,000

 

 

 

147,103,318

 

 

 

147,103

 

 

 

10,000

 

 

 

50,284,331

 

 

 

249,935

 

 

 

(54,149,162)

 

 

(3,456,793)

 

See(The accompanying notes to interimare an integral part of these condensed combinedconsolidated financial statementsstatements)

 

 
F-4
 
Table of Contents

 

FLOOIDCX CORP.

Condensed Consolidated Statements of Stockholders’ Deficit (continued)

(Expressed in U.S. dollars)

(unaudited)

 

 

Preferred Stock

 

 

Common Stock

 

 

Common Stock

 

 

Additional

Paid-in

 

 

Accumulated

Other Comprehensive

 

 

 

 

 

Total

Stockholders’

 

 

 

Shares

#

 

 

Amount

$

 

 

Shares

#

 

 

Amount

$

 

 

Issuable

$

 

 

Capital

$

 

 

Income

$

 

 

Deficit

$

 

 

Deficit

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, February 28, 2018

 

 

1,000,000

 

 

 

1,000

 

 

 

132,883,504

 

 

 

132,884

 

 

 

11,249

 

 

 

47,330,400

 

 

 

146,124

 

 

 

(50,570,351)

 

 

(2,948,694)

Shares issued pursuant to share exchange agreement

 

 

 

 

 

 

 

 

528,094

 

 

 

528

 

 

 

(528)

 

 

 

 

 

 

 

 

 

 

 

 

Shares to be issued pursuant to settlement of accounts payable

 

 

 

 

 

 

 

 

 

 

 

 

 

 

435

 

 

 

93,047

 

 

 

 

 

 

 

 

 

93,482

 

Share subscriptions received

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,071

 

 

 

373,929

 

 

 

 

 

 

 

 

 

375,000

 

Fair value of stock options granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

151,935

 

 

 

 

 

 

 

 

 

151,935

 

Foreign exchange translation gain

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

33,982

 

 

 

 

 

 

33,982

 

Net loss for the period

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(451,101)

 

 

(451,101)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, May 31, 2018

 

 

1,000,000

 

 

 

1,000

 

 

 

133,411,598

 

 

 

133,412

 

 

 

12,227

 

 

 

47,949,311

 

 

 

180,106

 

 

 

(51,021,452)

 

 

(2,745,396)

Shares issued for cash

 

 

 

 

 

 

 

 

2,506,720

 

 

 

2,506

 

 

 

(1,792)

 

 

249,286

 

 

 

 

 

 

 

 

 

250,000

 

Fair value of options granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

154,153

 

 

 

 

 

 

 

 

 

154,153

 

Foreign exchange translation gain

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

18,262

 

 

 

 

 

 

18,262

 

Net loss for the period

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(454,150)

 

 

(454,150)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance, August 31, 2018

 

 

1,000,000

 

 

 

1,000

 

 

 

135,918,318

 

 

 

135,918

 

 

 

10,435

 

 

 

48,352,750

 

 

 

198,368

 

 

 

(51,475,602)

 

 

(2,777,131)

Shares issued pursuant to settlement of accounts payable

 

 

 

 

 

 

 

 

435,000

 

 

 

435

 

 

 

(435)

 

 

 

 

 

 

 

 

 

 

 

 

Fair value of options granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

17,316

 

 

 

 

 

 

 

 

 

17,316

 

Foreign exchange translation gain

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

61,446

 

 

 

 

 

 

61,446

 

Net loss for the period

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(276,276)

 

 

(276,276)

Balance, November 30, 2018

 

 

1,000,000

 

 

 

1,000

 

 

 

136,353,318

 

 

 

136,353

 

 

 

10,000

 

 

 

48,370,066

 

 

 

259,814

 

 

 

(51,751,878)

 

 

(2,974,645)

(The accompanying notes are an integral part of these condensed consolidated financial statements)

F-5
Gripevine, Inc.Table of Contents

Notes to Interim Condensed Combined Financial Statements

For The Three and Nine Months Ended November 30, 2017

(Expressed in US dollars)

 

1. NATURE OF OPERATIONS

FLOOIDCX CORP.

Condensed Consolidated Statements of Cash Flows

(Expressed in U.S. dollars)

(unaudited)

 

 

 

Nine Months

Ended

November 30,

2019

$

 

 

Nine Months

Ended

November 30,

2018

$

 

 

 

 

 

 

 

 

Operating Activities

 

 

 

 

 

 

Net loss for the period

 

 

(2,264,644)

 

 

(1,181,527)

Adjustments to reconcile net loss to net cash used in operating activities:

 

 

 

 

 

 

 

 

Depreciation

 

 

5,945

 

 

 

9,545

 

Loss on settlement of debt

 

 

49,000

 

 

 

 

Shares issued for services

 

 

172,500

 

 

 

 

Stock-based compensation

 

 

1,373,465

 

 

 

323,404

 

Changes in operating assets and liabilities:

 

 

 

 

 

 

 

 

Prepaid expenses and deposits

 

 

9,069

 

 

 

(5,227)

Accounts payable and accrued liabilities

 

 

7,568

 

 

 

5,144

 

Deferred revenue

 

 

15,000

 

 

 

 

Due to related party

 

 

105,934

 

 

 

(868)

Net Cash Used In Operating Activities

 

 

(526,163)

 

 

(849,529)

 

 

 

 

 

 

 

 

 

Investing Activities

 

 

 

 

 

 

 

 

Purchase of property and equipment

 

 

(1,450)

 

 

(5,616)

Net Cash Used in Investing Activities

 

 

(1,450)

 

 

(5,616)

 

 

 

 

 

 

 

 

 

Financing Activities

 

 

 

 

 

 

 

 

Proceeds from loans payable

 

 

364,907

 

 

 

215,938

 

Repayment of loans payable

 

 

 

 

 

(5,446)

Proceeds from issuance of common stock

 

 

275,000

 

 

 

625,000

 

 

 

 

 

 

 

 

 

 

Net Cash Provided by Financing Activities

 

 

639,907

 

 

 

835,492

 

Effect of Foreign Exchange Rate Changes on Cash

 

 

(27,102)

 

 

6,914

 

Change in Cash

 

 

85,192

 

 

 

(12,739)

Cash, Beginning of Period

 

 

5,517

 

 

 

24,079

 

Cash, End of Period

 

 

90,709

 

 

 

11,340

 

 

 

 

 

 

 

 

 

 

Non-cash Investing and Financing Activities:

 

 

 

 

 

 

 

 

Shares issued to settle loans payable

 

 

224,000

 

 

 

 

Shares issued to settle accounts payable

 

 

 

 

 

93,482

 

 

 

 

 

 

 

 

 

 

Supplemental Disclosures:

 

 

 

 

 

 

 

 

Interest paid

 

 

 

 

 

 

Income taxes paid

 

 

 

 

 

 

(The accompanying notes are an integral part of these condensed consolidated financial statements)

F-6
Table of Contents

FLOOIDCX CORP.

Nine Months Ended November 30, 2019 and 2018

(Expressed in U.S. Dollars)

(unaudited)

1. Nature of Operations and Continuance of Business

flooidCX Corp. (formerly Gripevine, Inc. (formerlyand Baixo Relocation Services, Inc.) (the "Company"“Company”) was incorporated in the state of Nevada on January 7, 2014. The Company operated as a relocation service provider for clients moving tois in the Statebusiness of Goa, India and ceased this business and engaged in developing and building an online resolution platform after the Share Exchange Agreement as explained in the subsequent paragraphs. The Company's fiscal year-end is February end.platform.

 

MBE Holdings Inc. (“MBE”) was incorporated as a limited liability company on April 13, 2010 under the laws of the State of Delaware. MBE is engaged in research and development activities to offer an online complaint resolution platform for consumers and business, including ratings, reviews and polling’s. As such, its efforts to date have been devoted in building technology that enables access to this market through the development of a tangible product.

As explained in Note 7 to the condensed combined financial statements, on February 28, 2017,On May 17, 2019, the Company and MBEResolution 1, Inc. (“R1”) and the shareholders of MBER1 who collectively own 100% of MBER1 entered into and consummated transactions pursuant to a Share Exchange Agreement, whereby the Company agreed to issue to the MBER1 shareholders an aggregate of approximately 5,248,62610,000,000 shares of its common stock par value $0.001, in exchange for 100% of the equity interests of MBER1 held by the MBER1 shareholders. As a result of the share exchange, MBER1 became a wholly owned subsidiary of Gripevine.the Company.

 

As a result of the Share Exchange Agreement, the acquisition transaction has beenwas accounted for as a common control transaction in accordance with the Financial Accounting Standards Board (ASC(“FASB”) (Accounting Standard Codification (“ASC”) 805-50, Business Combinations – Common control transactions). The Company has evaluated the guidance contained in ASC 805805-50 with respect to the combinations among entities or businesses under common control and concludeconcluded that since the majority shareholdershareholders of the Company and MBER1 are the same, therefore, this iswas a common control transaction and dodid not result in a change in control at the ultimate parent or the controlling shareholder level.

 

Consequently, common control transactions are not accounted for at fair value. Rather, common control transactions are generally accounted for at the carrying amount of the net assets or equity interests transferred. Any differences between the proceeds received or transferred and the carrying amounts of the net assets are considered equity transactions that would be eliminated in consolidation, and no gain or loss would be recognized in the condensed combinedconsolidated financial statements of the ultimate parent. Resultantly,As a result, the financial position and the results of operations of Gripevinethe Company and MBE are combinedR1 were consolidated together as if they were operating as one entity from the beginning.

 

2. BASIS OF PRESENTATION AND COMBINATION

The accompanying unaudited condensed combined financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“US GAAP”) for interim financial information and the Securities Exchange Commission (“SEC”) instructions to Form 10-Q and Article 8 of SEC Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements and should be read in conjunction with the Company’s audited combined financial statements for the years ended February 28, 2017 and February 29, 2016 and notes thereto included in the Form 10-K filed with the SEC on June 14, 2017. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation of combined financial position and results of operations for the interim periods presented have been reflected herein. Operating results for the nine months ended November 30, 2017, are not necessarily indicative of the results that may be expected for the year ending February 28, 2018.

F-5
Table of Contents

Gripevine, Inc.

Notes to Interim Condensed Combined Financial Statements

For The Three and Nine Months Ended November 30, 2017

(Expressed in US dollars)

2. BASIS OF PRESENTATION AND COMBINATION (continued)

As explained above in Note 1 to the unaudited condensed combined financial statements, as a result of the Share Exchange Agreement, the acquisition transaction has been accounted for as a common control transaction in accordance with the Financial Accounting Standards Board (ASC 805-50, Business Combinations – Common control transactions). Consequently, the condensed combined financial statements have been prepared as if the Company and MBE were a single organization by the aggregation of their financial statements from the beginning of the previous period and the elimination of transactions and balances between them.

3. GOING CONCERN

The unaudited condensed combinedThese consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company has incurred recurring losses from operations and as at November 30, 2017 and February 28, 2017 had a working capital deficiency of $2,745,680 and $2,618,599, respectively and an accumulated deficit of $48,279,952 and $46,634,969 respectively. Management anticipatesimplies the Company will attain profitable status and improve its liquidity through continued business development and additional debt or equity investment in the Company. The Company’s continued existence is dependent upon its ability to continue to execute its operating plan and to obtain additional debt or equity financing. There can be no assurance that the necessary debt or equity financing will be available, or will be available on terms acceptable to the Company, in which case the Company may be unable to meet its obligations. Should the Company be unable to realize its assets and discharge its liabilities in the normal course of business,business. The continuation of the net realizable valueCompany as a going concern is dependent upon the continued financial support from its shareholders, creditors, and related parties, and the ability of its assets may be materially less than the amounts recordedCompany to obtain necessary equity financing to continue operations, and ultimately the attainment of profitable operations. As at November 30, 2019, the Company has a working capital deficit of $3,477,078 and has an accumulated deficit of $54,149,162 since inception. Furthermore, during the nine months ended November 30, 2019, the Company used $526,163 in operating activities. These factors raise substantial doubt regarding the condensed combined financial statements. The condensed combinedCompany’s ability to continue as a going concern. These consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue in existence.as a going concern.

 

4. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES2. Significant Accounting Policies

 

Use(a) Basis of EstimatesPresentation

 

The preparation of unaudited condensed combined financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed combinedThese consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Areas involving significant estimates and assumptions include: deferred income tax assets and related valuation allowance and accruals. Actual results could differ from those estimates. These estimatesnotes are reviewed periodically, and, as adjustments become necessary, they are reportedpresented in earningsaccordance with accounting principles generally accepted in the periodUnited States, and are expressed in which they become known.

Loss Per Share

TheU.S. dollars. These consolidated financial statements include the accounts of the Company has adoptedand the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 260-10 which provides for calculation of “basic” and “diluted” earnings per share. Basic earnings per share includes no dilution and is computed by dividing net income or loss available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of an entity. Diluted earnings per share exclude all potentially dilutive shares if their effect is anti-dilutive. There were no potentially dilutive shares outstanding as at November 30, 2017 and 2016.

Fair Value of Financial Instruments

ASC 820 defines fair value, establishes a framework for measuring fair value and expands required disclosure about fair value measurements of assets and liabilities. ASC 820-10 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820-10 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

F-6
Table of Contents
following entities:

 

Gripevine,MBE Holdings Inc.

Notes to Interim Condensed Combined Financial StatementsWholly-owned subsidiary

For The Three and Nine Months EndedResolution 1, Inc.

Wholly-owned subsidiary (effective November 30, 2017

(Expressed in US dollars)

4. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

·

Level 1 – Valuation based on quoted market prices in active markets for identical assets or liabilities.

·

Level 2 – Valuation based on quoted market prices for similar assets and liabilities in active markets.

·

Level 3 – Valuation based on unobservable inputs that are supported by little or no market activity, therefore requiring management’s best estimate of what market participants would use as fair value.2019, this subsidiary was amalgamated with the Company)

 

In instances where the determinationAll inter-company balances and transactions have been eliminated.

(b) Reclassifications

Certain of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significantprior period figures have been reclassified to conform to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability.current period’s presentation.

 

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management. The respective carrying value of certain on-balance-sheet financial instruments approximated their fair values due to the short-term nature of these instruments or interest rates that are comparable to market rates. These financial instruments include cash and accounts payable. The Company's cash, which is carried at fair value, is classified as a Level 1 financial instrument. The Company’s bank accounts are maintained with financial institutions of reputable credit, therefore, bear minimal credit risk.

Stock Based Compensation

The Company accounts for share-based payments in accordance with the provision of ASC 718, which requires that all share-based payments issued to acquire goods or services, including grants of employee stock options, be recognized in the statement of operations based on their fair values, net of estimated forfeitures. ASC 718 requires forfeitures to be estimated at the time of grant and revised, if necessary, in subsequent periods if actual forfeitures differ from those estimates. Compensation expense related to share-based awards is recognized over the requisite service period, which is generally the vesting period. The Company accounts for stock based compensation awards issued to non-employees for services, as prescribed by ASC 718-10, at either the fair value of the services rendered or the instruments issued in exchange for such services, whichever is more readily determinable, using the guidelines in ASC 505-50. The Company issues compensatory shares for services including, but not limited to, executive, management, accounting, operations, corporate communication, financial and administrative consulting services.

Recently Issued Accounting Pronouncements

In May 2017, an accounting pronouncement was issued by the Financial Accounting Standards Board (“FASB”) ASU 2017-09, “Compensation - Stock Compensation: Scope of Modification Accounting.” ASU 2017-09 provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting. The updated guidance is effective for interim and annual periods beginning after December 15, 2017, and early adoption is permitted. The adoption of this pronouncement will not have a material impact on the unaudited condensed combined financial position and/or results of operations.

On January 1, 2017, the Company adopted the accounting pronouncement issued by the FASB to simplify the presentation of deferred income taxes within the balance sheet. This pronouncement eliminates the requirement that deferred tax assets and liabilities are presented as current or noncurrent based on the nature of the underlying assets and liabilities. Instead, the pronouncement requires that all deferred tax assets and liabilities, including valuation allowances, be classified as noncurrent. We adopted this pronouncement on a retrospective basis. The adoption of this guidance did not have a material impact on the Company’s unaudited condensed combined financial position and/or results of operations.

 
F-7
 
Table of Contents

 

Gripevine, Inc.

Notes to Interim Condensed Combined Financial Statements

For The Three and Nine Months Ended November 30, 2017

(Expressed in US dollars)

FLOOIDCX CORP.

Notes to the Condensed Consolidated Financial Statements

Nine Months Ended November 30, 2019 and 2018

(Expressed in U.S. Dollars)

(unaudited)

 

4. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

2. Significant Accounting Policies (continued)

 

On January 1, 2017,(c) Interim Financial Statements

The accompanying condensed consolidated financial statements of the Company adoptedshould be read in conjunction with the consolidated financial statements and accompanying notes filed with the U.S. Securities and Exchange Commission in the Company’s Annual Report on Form 10-K for the fiscal year ended February 28, 2019. In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments of a recurring nature considered necessary to present fairly the Company’s financial position and the results of its operations and its cash flows for the periods shown.

The preparation of these condensed consolidated financial statements in accordance with accounting pronouncement issuedprinciples generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ materially from those estimates. The results of operations and cash flows for the periods shown are not necessarily indicative of the results to be expected for the full year.

(d) Revenue Recognition

The Company will derive revenue from developing and building online resolution platforms. Under ASC 606, “Revenue from Contracts with Customers”, the Company recognizes revenue by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied.

(e) Recent Accounting Pronouncements

In February 2016, the FASB issued new lease accounting guidance in ASU No. 2016-02, “Leases”. This new guidance was initiated as a joint project with the International Accounting Standards Board to simplify lease accounting and improve the accountingquality of and comparability of financial information for goodwill impairment.users. This new guidance eliminateswould eliminate the requirement that an entity calculateconcept of off-balance sheet treatment for “operating leases” for lessees for the implied fair valuevast majority of goodwill when measuring an impairment charge. Instead, an entity would record an impairment charge basedlease contracts. Under ASU No. 2016-02, at inception, a lessee must classify all leases with a term of over one year as either finance or operating, with both classifications resulting in the recognition of a defined “right-of-use” asset and a lease liability on the excessbalance sheet. However, recognition in the income statement will differ depending on the lease classification, with finance leases recognizing the amortization of the right-of-use asset separate from the interest on the lease liability and operating leases recognizing a reporting unit’s carrying amount over its fair value. The Company adopted this pronouncement on a prospective basis.single total lease expense. Lessor accounting under ASU No. 2016-02 would be substantially unchanged from the previous lease requirements under GAAP. ASU No. 2016-02 will take effect for public companies in fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The adoption of this guidancestandard on March 1, 2019, did not have any impact on the Company’s consolidated financial statements.

In August 2018, the FASB issued ASU 2018-13, “Changes to Disclosure Requirements for Fair Value Measurements”, which will improve the effectiveness of disclosure requirements for recurring and nonrecurring fair value measurements. The standard removes, modifies, and adds certain disclosure requirements, and is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company will be evaluating the impact this standard will have on the Company’s consolidated financial statements.

The Company has implemented all new accounting pronouncements that are in effect and that may impact its consolidated financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on the Company’s unaudited condensed combinedits financial position and/or results of operations.

 

In February 2016, an accounting pronouncement was issued by the FASB to replace existing lease accounting guidance. This pronouncement is intended to provide enhanced transparency3. Property and comparability by requiring lessees to record right-of-use assets and corresponding lease liabilities on the balance sheet for most leases. Expenses associated with leases will continue to be recognized in a manner similar to current accounting guidance. This pronouncement is effective for annual and interim periods beginning after December 15, 2018, with early adoption permitted. The adoption is required to be applied on a modified retrospective basis for each prior reporting period presented. The Company has not yet determined the effect that the adoption of this pronouncement may have on its unaudited condensed combined financial position and/or results of operations.Equipment

 

5. EQUIPMENT

 

 

As at

November 30,

 

 

As at

February 28,

 

 

 

2017

 

 

2017

 

 

 

$

 

 

$

 

Furniture

 

 

38,192

 

 

 

31,889

 

Computer equipment

 

 

32,207

 

 

 

24,864

 

Total cost

 

 

70,399

 

 

 

56,753

 

Less: Accumulated depreciation

 

 

(33,390)

 

 

(15,098)

 

 

 

37,009

 

 

 

41,655

 

6. LOANS PAYABLE/DUE TO RELATED PARTIES / DUE TO A SHAREHOLDER

Loans payable

Loans payable represents advances from a related corporation to meet the working capital requirements of the Company. These advances are interest free, unsecured and are repayable on demand.

Due to related parties and due to a shareholder

The balances due to related parties and a shareholder are mainly in connection with the consulting services and financing provided for the development of an online complaint resolution platform as explained in Note 1 to the condensed combined financial statements. These balances are interest free, unsecured and are repayable on demand.

 

 

As at

November 30,
2019

$

 

 

As at

February 28,
2019

$

 

 

 

 

 

 

 

 

Computer equipment

 

 

37,040

 

 

 

37,377

 

Furniture and equipment

 

 

38,181

 

 

 

37,067

 

 

 

 

 

 

 

 

 

 

Total

 

 

75,221

 

 

 

74,444

 

Less: Accumulated depreciation

 

 

(54,936)

 

 

(49,435)

Net carrying value

 

 

20,285

 

 

 

25,009

 

 

 
F-8
 
Table of Contents

 

Gripevine, Inc.FLOOIDCX CORP.

Notes to Interim Condensed Combined Financial Statements

For The Three and Nine Months Ended November 30, 2017

(Expressed in US dollars)

7. STOCKHOLDERS’ DEFICIENCY

Share Exchange Agreement

On February 28, 2017, the Company, MBE and the shareholders of MBE entered into a Share Exchange Agreement (the “Share Exchange Agreement”). The Board of Directors of the Company approved the execution and consummation of the transaction under the Share Exchange Agreement on February 28, 2017.

In accordance with the terms and provisions of the Share Exchange Agreement, the Company is to issue an aggregate of 5,248,626 shares of its restricted common stock to the MBE ShareholdersCondensed Consolidated Financial Statements

Nine Months Ended November 30, 2019 and 2018

(Expressed in exchange for 157,458,778 of the total issued and outstanding shares of MBE (constituting 100%), thus making MBE its wholly-owned subsidiary. The Board of Directors of the Company and MBE deemed it in the best interests of the respective shareholders to enter into the Share Exchange Agreement pursuant to which the Company would acquire all the technology and assets and assume all liabilities of MBE.U.S. Dollars)

(unaudited)

 

Authorized stock4.

On October 31, 2016, the Board of Directors of the Company authorized an increase in the Company's shares of common stock to three hundred million (300,000,000) shares with par value remaining at $0.001 and creation of twenty million (20,000,000) shares of preferred stock, par value $0.001. On November 4, 2016, the Company filed a Certificate of Amendment with the Nevada Secretary of State increasing its authorized capital to 300,000,000 shares of common stock, par value $0.001, and 20,000,000 shares of preferred stock, par value $0.001 (the “Amendment). The Amendment was effective with the Nevada Secretary of State on November 4, 2016 when the Certificate of Amendment was filed. The Amendment was approved by the Board of Directors pursuant to written consent resolutions dated October 31, 2016 and further approved by the shareholders holding a majority of the total issued and outstanding shares of common stock of the Company pursuant to written consent resolutions dated October 31, 2016.

Common stock issued and outstandingLoans Payable

On May 31, 2016 and effective October 3, 2016, the Company’s previous majority shareholder, sole executive officer and member of the Board of Directors, entered into certain stock purchase agreements (collectively, the “Stock Purchase Agreements”) with certain individuals and/or entities (collectively, the “Investors”). In accordance with the terms and provisions of the Stock Purchase Agreements, the then majority shareholder sold and transferred at a per share price of $0.037 the control block of the Company consisting of 5,000,000 shares of restricted common stock and representing approximately 62.5% of the total issued and outstanding shares of common stock.

During the quarter period ended, November 30, 2017, the Company issued 4,720,532 shares in connection with the Share Exchange Agreement as explained above. The remaining shares of 528,094 are included in common stock to be issued.

 

As at November 30, 20172019, the Company has 124,720,532 outstanding common stock comprising of 79,717,199 restricted stockowed $2,694,314 (Cdn$3,580,474) (February 28, 2019 – $2,526,650 (Cdn$3,326,587)) which is non-interest bearing, unsecured, and 45,003,333 unrestricted stock. As at February 28, 2017, the Company has 120,000,000 outstanding common stock comprising of 75,000,000 restricted stockdue on demand. Refer to Notes 6(c) and 45,000,000 unrestricted stock.(d).

 

Common stock to be issued5. Related Party Transactions

 

(a) As at November 30, 2019, the Company owed $738,994 (Cdn$982,050) (February 28, 2019 – $633,060 (Cdn$833,486)) to the President of the Company which is unsecured, non-interest bearing, and due on demand.

(b) During the nine months ended November 30, 2019, the Company incurred $135,522 (2018 – $138,378) in research and development fees to the President of the Company.

(c) During the nine months ended November 30, 2019, the Company incurred $28,272 (2018 – $28,991) in research and development fees to the Chief Operating Officer of the Company.

(d) During the nine months ended November 30, 2019, the Company incurred $6,400 (2018 - $35,388) in administrative fees included in general and administrative to the office manager who is also the spouse of the President of the Company.

(e) During the nine months ended November 30, 2019, the Company recognized stock-based compensation of $1,236,760 (2018 - $104,024) to the President, spouse of the President, and Chief Operating Officer of the Company.

6. Common Stock

(a) During the three months ended November 30, 2019, the Company issued 4,500,000 shares of common stock at $0.05 per share for proceeds of $225,000.

(b) On October 11, 2019, the Company issued 2,500,000 shares of common stock with a fair value of $172,500 for financial advisory and investment bank services to be issued of 3,022,844 shares comprise of:provided. Refer to Note 9(b).

 

(c) On November 4, 2019, the Company issued 1,500,000 shares of common stock with a fair value of $96,000 to settle a loan payable $75,000, resulting in a loss of $21,000. The fair value of the common stock was determined based on the closing price of the Company’s common stock on the date of issuance.

 

(d) On November 4, 2019, the Company issued 2,000,000 shares of common stock with a fair value of $128,000 to settle a loan payable of $100,000, resulting in a loss of $28,000. The fair value of the common stock was determined based on the closing price of the Company’s common stock on the date of issuance.

7. Share Purchase Warrants

 

 

Number of

warrants

 

 

Weighted average exercise price

$

 

 

 

 

 

 

 

 

Balance, February 28, 2019 and November 30, 2019

 

 

18,275,000

 

 

 

0.40

 

As at November 30, 2019, the following share purchase warrants were outstanding:

Number of warrants outstanding

 

 

Exercise

price

$

 

 

Expiry
date

 

 

 

 

 

 

 

 

 
18,275,000

 

 

 

0.40

 

 

December 1, 2019

 

·528,094 shares in connection with the “Share Exchange Agreement” as explained above.

·During June and August 2017, the Company sold 1,445,657 shares of common stock to nine investors through a private placement at a price of $0.35 per common stock and received gross proceeds of $505,980.

·During September, October and November 2017, the Company sold 1,049,093 shares of common stock to six investors through a private placement at a price of $0.35 per common stock and received gross proceeds of $367,183.

 

 
F-9
 
Table of Contents

 

Gripevine, Inc.FLOOIDCX CORP.

Notes to the Condensed Consolidated Financial Statements

Nine Months Ended November 30, 2019 and 2018

(Expressed in U.S. Dollars)

(unaudited)

Notes to Interim Condensed Combined Financial Statements

For The Three and Nine Months Ended November 30, 2017

(Expressed in US dollars)

7. STOCKHOLDERS’ DEFICIENCY (continued)

Preferred stock8. Stock Options

 

On April 20, 2017,The following table summarizes the Boardcontinuity of Directors authorized the issuance of the 1,000,000 shares of Series A Preferred Stock to its sole executive officer and member of the Board of Directors in consideration of his services performed during the year ended February 28, 2017. These preferred stocks contain certain rights and preference as detailed below:stock options:

 

·

In the event of acquisition of the Company, the preferred stock holder to receive 20% of the aggregate valuation of such merger;

·

The holder can convert each share of preferred stock into 100 shares of common stock; and

·

Each holder of preferred stock shall be entitled to cast 200 votes.

 

 

Number of

options

 

 

Weighted average exercise price

$

 

 

Aggregate intrinsic value

$

 

 

 

 

 

 

 

 

 

 

 

Balance, February 28, 2019

 

 

5,706,500

 

 

 

0.20

 

 

 

 

Granted

 

 

11,050,000

 

 

 

0.20

 

 

 

 

Balance, November 30, 2019

 

 

16,756,500

 

 

 

0.20

 

 

 

 

Additional information regarding stock options outstanding as at November 30, 2019 is as follows:

 

 

 

Outstanding and exercisable

 

Range of

exercise prices

$

 

 

Number of
shares

 

 

Weighted average remaining contractual life (years)

 

 

Weighted average

exercise price

$

 

 

 

 

 

 

 

 

 

 

 

 

0.20

 

 

 

16,756,500

 

 

 

5.25

 

 

 

0.20

 

 

The fair value of these 1,000,000 preferred stock amounting to $38,694,414options granted was determined by an independent valuation using the assumptions i. e. conversion value, control premium of 11.15% based on similar publicly trading companies, voting and sale/merger rights of the stock and stock price of $0.69. As the issuance of preferred stock related to past services, therefore, this amount was recorded as stock based compensation in the combined statements of operations during the previous year ended February 28, 2017. The charge relating to three and nine months ended November 30, 2016 amounts to $9,673,604 and $29,020,811.

Warrants

On December 1, 2016, the Company issued 18,275,000 warrants to certain shareholders of the Company for their services for the year ended February 28, 2017. These warrants have a strike price of $0.40 and will expire on December 1, 2019. The fair value of these warrants was measured at the date of grantestimated using the Black-Scholes option pricing model usingassuming no expected dividends or forfeitures and the following weighted average assumptions:

 

 

 

Nine months ended

November 30,

2019

 

 

Nine months ended

November 30,

2018

 

 

 

 

 

 

 

 

Risk-free interest rate

 

 

2.12%

 

 

1.49%

Expected life (in years)

 

 

5

 

 

 

5

 

Expected volatility

 

 

245%

 

 

290%

·Forfeiture rate of 0%;

·Stock price of $0.12 per share;

·Exercise price of $0.4 per share;

·Volatility at 265.20%;

·Risk free interest rate of 1.45%;

·Expected life of 3 years; and

·Expected dividend rate of 0%

 

At grant date theThe fair value of these warrants were determined at $2,110,333. Asstock options recognized during the issuance of warrants related to past services, therefore, this amountnine months ended November 30, 2019 was $1,373,465 (2018 - $323,404), which was recorded as additional paid-in capital and charged to operations. The weighted average fair value of stock based compensation in the combined statements of operationsoptions granted during the year (fourth quarter)nine months ended February 28, 2017.

As at November 30, 2017 and February 28, 2017, there were 18,275,000 warrants were outstanding, fully vested and with a remaining contractual life term of 2.00 and 2.75 years, respectively.2019 was $0.20 (2018 – $0.20) per option.

 

Stock Based Options9. Commitments

(a) The minimum lease payments over the remaining terms of the premises leases are as follows:

Fiscal Year

 

$

 

 

 

 

 

2020

 

 

6,543

 

(b) On October 7, 2019, the Company entered into an agreement with a company who is to provide general financial advisory and investment banking services to the Company. The Company is to pay this company $5,000 per month for a period of six months. The monthly fee can be paid in cash or in shares at the Company’s option. If paid in shares of common stock of the Company, the shares shall be valued using the volume-weighted average price of the shares for the five trading days immediately preceding each monthly fee payment due date. The Company is to issue 2,500,000 shares of common of stock upon execution of the agreement (issued) and 2,500,000 shares of common stock upon an uplisting of the Company’s common stock to a national exchange. For any financing, the Company will pay this company a commission of 8% of financing raised, a cash fee for unallocated expenses of 1% of the amount of financing raised, and issue agent’s warrants equal to 8% of the number of shares of common stock underlying the securities issued in the financing. Each agent’s warrant will be exercisable at an exercise price equal to the price of the securities issued to the investors in the financing expiring five years from the date of issuance.

10. Subsequent Event

 

On August 16, 2017,December 23, 2019, the Company approved Directors, Officers, Employees and Consultants Stock Option Plan, under which it authorized 50,000,000 options and issued 5,486,500 options. This plan was established to enable the Company to attract and retain the services1,500,000 shares of highly qualified and experience directors, officers, employees and consultants and to give such person an interest in the successcommon stock for proceeds of the Company.$75,000.

 

 
F-10
 
Table of Contents

Gripevine, Inc.

Notes to Interim Condensed Combined Financial Statements

For The Three and Nine Months Ended November 30, 2017

(Expressed in US dollars)

7. STOCKHOLDERS’ DEFICIENCY (continued)

On November 27, 2017, the Company approved the issue of a second tranche of 120,000 options to a new Director of the Company pursuant to the Directors, Officers, Employees and Consultants Stock Option Plan, under which it authorized 50,000,000 options.

As at November 30, 2017, the company has issued 5,606,500 options.

The fair value of each option granted is estimated at the time of grant using Black-Scholes option pricing model with the following assumptions:

·Forfeiture rate of: Tranche 1- 0%; Tranche 2 – 0%

·Stock price of: Tranche 1 - $0.20 per share; Tranche 2 - $0.20 per share

·Volatility at: Tranche 1 - 291%; Tranche 2 – 259%

·Market price of: Tranche 1 - $0.20 per share; Tranche 2 - $0.20 per share

·Risk free interest rate of: Tranche 1 - 1.49%; Tranche 2 – 1.62%

·Expected life of: Tranche 1 - 5 years; Tranche 2 – 5 years

·Expected dividend rate of: Tranche 1 - 0%; Tranche 2 – 0%

·Fair value of options of: Tranche 1 - $0.20; Tranche 2 - $0.20

For Tranche 1, 50% of the grants will vest immediately and 50% will vest one year from grant date and for Tranche 2, 100% of the grants vest immediately.

All grants will expire on the fifth anniversary of the grant date. The risk-free interest rate is based on the yield of U.S. Treasury securities that correspond to the expected holding period of the options. The volatility was determined based on company’s historical stock prices. The expected forfeiture (attrition) rates were based on the position of the consultants receiving the options. The dividend yield was based on an expected future dividend rate for the period at the time of grant.

The following table summarizes the stock option activities of the Company:

 

 

Number

of options

 

 

Weighted average exercise

price ($)

 

Granted

 

 

5,606,500

 

 

 

0.200

 

Excercised

 

 

 

 

 

0.200

 

Outstanding as of November 30, 2017

 

 

5,606,500

 

 

 

0.200

 

The fair value of tranche 1 options at the issuance date was determined at $1,087,917 out of which $136,076 and $725,046 were expensed during the three and nine months ended November 30, 2017 respectively based on vesting period and were included in stock based compensation with corresponding credit to additional paid-in-capital.

The fair value of tranche 2 options at the issuance date was determined at $19,353 and expensed entirely in the quarter ended November 30, 2017.

As at November 30, 2017 there were 5,606,500 stock options outstanding, 2,863,250 vested and with a remaining contractual life term of 4.71 years

F-11
Table of Contents

Gripevine, Inc.

Notes to Interim Condensed Combined Financial Statements

For The Three and Nine Months Ended November 30, 2017

(Expressed in US dollars)

8. RELATED PARTY TRANSACTIONS AND BALANCES

The Company’s transactions with related parties were carried out on normal commercial terms and in the normal course of the Company’s business. Other than disclosed elsewhere in the unaudited condensed combined financial statements, the related party transactions and balances are as follows:

Research and development expenses for the three and nine months ended November 30, 2017 include consulting charges from shareholders and related parties of $54,524 and $182,619, respectively (2016: $104,267 and $273,335 respectively).

9. COMMITMENTS

On March 8, 2016, the Company entered into an operating lease contract for its office premises in Oakville, Ontario for a three year and eight months term commenced from May 1, 2016. The monthly lease payment is between $3,350 to $4,890 plus applicable taxes.

On December 6, 2016, the Company entered into a second operating lease contract for its additional office premises in Oakville, Ontario for a three year term commencing from January 1, 2017. The monthly lease payment is between $2,500 to $3,800 plus applicable taxes.

10. SUBSEQUENT EVENTS

The Company’s management has evaluated subsequent events up to January 16, 2018, the date the condensed combined financial statements were issued, pursuant to the requirements of ASC 855 and has determined the following material subsequent events:

During December 2017, the Company sold 428,571 shares of common stock to one investor through a private placement at a price of $0.35 per common stock and received gross proceeds of $150,000.

During December 2017, our Board of Directors (the “Board”) approved an aggregate of 5,674,944 shares of our restricted common stock to certain non-affiliated consultants (the “Consultants”) in consideration of various services rendered to the Company. As of the date of this Quarterly Report, these shares are not issued.

F-12
Table of Contents

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The following discussion provides an analysis of the Company’s financial condition and results of operations and should be read in conjunction with the Interim Condensed CombinedConsolidated Financial Statements and notes thereto included in Item 1 of Part I of this Quarterly Report on Form 10-Q and with the Company’s Annual Report on Form 10-K filed for the fiscal year ended February 28, 2017.2019. The discussion contains forward-looking statements that involve risks, uncertainties and assumptions. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of many factors.

 

Overview

 

Gripevine, Inc.flooidCX Corp., formerly known as Gripevine, Inc. (the “Company”), was incorporated under the name Baixo Relocation Services, Inc. (the "Company"), was incorporated in the state of Nevada on January 7, 2014.2014, to operate as a relocation service provider for clients moving to the State of Goa, India. On May 31, 2016, Rosy Rodrigues, (“Rodrigues”), our prior majority shareholder, sole executive officer and member of the Board of Directors, entered into those certain stock purchase agreements effective October 3, 2016 (collectively, the “Stock Purchase Agreements”) with certain individuals and/or entities, (collectively, the “Investors”). In accordance with the terms and provisions of the Stock Purchase Agreements, Rodrigues sold and transferred the control block of the Company consisting of 5,000,000 shares of restricted common stock, at a per share price of $0.037, representing approximately 62.5% of the total issued and outstanding shares of common stock and resulting in a change in control. The Company operated as a relocation service provider for clients moving to the State of Goa, India.

Effective February 28, 2017, we entered into a share exchange agreement (the “Share“MBE Exchange Agreement”) with MBE Holdings Inc., a private corporation organized under the laws of Delaware (“MBE”) and the shareholders of MBE (the “MBE Shareholders”), pursuant to which ShareMBE Exchange Agreement we acquired all the technology and assets and assumeassumed all liabilities of MBE, and MBE became our wholly-owned subsidiary. In accordance with the terms and provisions of the ShareMBE Exchange Agreement, an aggregate of 5,248,626 shares of our restricted common stock are to bewere issued to the MBE Shareholders in exchange for 157,458,778 of the total issued and outstanding shares of MBE. As

Effective March 18, 2019, we changed our name to flooidCX Corp. pursuant to Certificate of Amendment to its Articles of Incorporation filed with the Nevada Secretary of State. The name of the dateCompany was changed as part of this Quarterly Report, an aggregate 4,720,532our rebranding, which better reflects our new business direction into the customer care and feedback solutions space – offering easy to adapt customer care and feedback solutions to enterprises of all sizes.

On May 17, 2019, we entered into a Share Exchange Agreement (the “R1 Exchange Agreement”) with the stockholders of Resolution 1, Inc., a Delaware corporation (“R1”), to acquire all of the outstanding shares of R1 in exchange for 10,000,000 restricted shares of our restricted common stock have been issued to the MBE Shareholders. See “Part II. Item 2. Unregistered Sales of Equity Securities(the “Acquisition”). R1 has developed a comprehensive customer care and Use of Proceeds – Share Exchange Agreement”.

MBE was formedfeedback management platform, which is delivered as a limited liability company on April 13, 2010,cloud-based, software as a service solution. R1 was founded in August 2012 by Richard Hue, the CEO and subsequently converted into a corporation on August 3, 2012, underdirector of our Company. The Acquisition was approved by the lawsindependent members of the Stateboard of Delaware. MBE is engaged in research and development activities to offer an online complaint resolution platform for consumers and business, including ratings, reviews and polling’s. As such, its efforts to date have been devoted in building technology that enables access to this market throughdirectors of the development of a tangible product. The Share Exchange Agreement resulted in a change in overall business operationsCompany. Since the majority shareholders of the Company bringing potential value to our shareholders. Followingand R1 are the Share Exchange Agreement, we ceased operationssame, this did not result in the change in control at the ultimate parent or the controlling shareholder level, and was accounted for as a relocation service provider and engaged in developing and building an online resolution platform.common control transaction.

 

SinceOur mission is to help businesses bring back the conversation with customers with innovative, simple to use solutions that empower both the businesses and customers to communicate and create positive outcomes. With the consummation of the ShareR1 Exchange Agreement resulting in MBER1 being our wholly-owned subsidiary, we have been involved in the ongoing developmentnow offer a suite of customer relationship management (CRM) solutions that enhances and marketing of “Gripevine”, which is a social customer experience platform for social customer service and consumer reviews. “Gripevine” includes a proprietary process to assist companies in resolving customer service complaints (the “Gripevine Proprietary Process” or “Gripevine”). The Gripevine Proprietary Process helps consumers achieve resolutions while enabling businesses to improve consumer loyalty. Our platform includes the handling of ratings, reviews, complaint resolution statuses whilebuilds upon our initial offering, data collection features such as scoring, polling, comments, voting, and credibility points – all with the aim of creating a home for connections, resolution, business improvement, and loyalty enhancement. Consumers with legitimate customer service complaints can post it (“plant a gripe”) and connect with companies who in turn can interact with their customers on a level playing field to find an amicable resolution.“GripeVine.”

 

Unlike other review sitesWe offer unified communications and collaboration online CRM solutions - GripeVine and Resolution1. GripeVine is a consumer-to-business platform that cater specificallyhelps build a customer feedback-minded community, focused on transparency, mutual respect and open communications among like-minded customers and businesses – all working together – to accumulatingfacilitate positive outcomes. It allows for private messaging between customers and displaying consumer feedback, the Gripevine business model offers significant value to both consumers and businesses. Management of the Corporation believesbusinesses for positive resolutions, so that the Gripevine Proprietary Process brings fairness and balance by: (i) ensuring users are real; (ii) allowing companies to reach out and verify customer identity; (iii) flagging as fake those consumers whobusinesses are not identifiable;forced to communicate via the comments section. Resolution1 functions as a cloud-based customer care and (iv) providing companies free accessfeedback workflow management platform, where businesses can manage the entire logistics of customer care, feedback or inquiries throughout their entire organizations. Businesses can respond quickly and accurately to their customers. Gripevine’s unique proposition incustomers, while keeping track of every customer interaction. The platform is designed to grow and scale, so that businesses of all sizes, from small to medium-size enterprises (SMEs) to large enterprises, can use this socialcloud-based customer experience space is to create consumer-company connections in order to drive loyalty through efficientcare and effective handling of online customer feedback and commentary.management system.

4
Table of Contents

  

Results of Operations

 

The following discussions are based on our unaudited interim condensed combinedconsolidated financial statements, including our wholly owned subsidiary.wholly-owned subsidiaries. These charts and discussions summarize our unaudited interim consolidated financial statements for the three and nine month periodnine-month periods ended November 30, 2017 and November 30, 2016,2019, and should be read in conjunction with the Company’s audited combinedconsolidated financial statements for the yearsyear ended February 28, 2017 and February 29, 20162019 and notes thereto included in the Form 10-K filed with the SEC on June 14, 2017.13, 2019.

 

The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. The Corporation’sOur actual results could differ materially from those discussed in the forward lookingforward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to those discussed below and elsewhere in this Quarterly Report on Form 10-Q. The financial statements are stated in United States Dollars and are prepared in accordance with United States Generally Accepted Accounting Principles.

 

Three-Month Period Ended November 30, 2019 Compared to Three-Month Period Ended November 30, 2018

Revenue. We did not generate any revenue during the three months ended November 30, 2019 or 2018.

Operating expenses: During the quarter ended November 30, 2019, we incurred operating expenses in the amount of $658,728 compared to operating expenses incurred during the quarter ended November 30, 2018 of $276,276 (an increase of $382,452). Operating expenses include: (i) general and administrative of $346,650 (2018: $117,636); and (ii) research and development of $316,078 (2018: $158,640). General and administrative expenses increased by $229,014 due to issuance of shares for financial services and stock-based compensation. Research and development expenses increased by $157,438 due to increase in stock-based compensation.

Nine-Month Period Ended November 30, 2019 Compared to Nine-Month Period Ended November 30, 2018

Revenue. We did not generate any revenue during the nine months ended November 30, 2019 or 2018.

Operating expenses: During the nine months ended November 30, 2019, we incurred operating expenses in the amount of $2,215,644 compared to operating expenses incurred during the nine months ended November 30, 2018 of $1,181,527 (an increase of $1,034,117). Operating expenses include: (i) general and administrative of $730,209 (2018: $385,863); and (ii) research and development of $1,485,435 (2018: $795,664). General and administrative expenses increased by $344,346 due to new stock options and issuance of shares as compensation in general and administrative services. Research and development expenses increased by $689,771 due to new stock options as compensation in research and development expenses.

Liquidity and Capital Resources

As of November 30, 2019

As at November 30, 2019, our current assets were $100,098 and our current liabilities were $3,577,176, which resulted in a working capital deficit of $3,477,078. As of November 30, 2019, current assets were comprised of: (i) $90,709 in cash; and (ii) $9,389 in prepaid expenses and deposits. Also as of November 30, 2019, current liabilities were comprised of: (i) $128,868 in accounts payable and accrued liabilities; (ii) $15,000 in deferred revenue; (iii) $2,694,314 in loans payable and (iv) $738,994 due to related party.

As of November 30, 2019, our total assets were $120,383 comprised of: (i) current assets of $100,098; and (ii) equipment, net of depreciation of $20,285. The increase in total assets during the nine months ended November 30, 2019 from the fiscal year ended February 28, 2019 was due to an increase in cash, offset by decreases in prepaid expenses and deposits and the depreciated value of equipment.

As of November 30, 2019, our total liabilities were $3,577,176 comprised of current liabilities.

Stockholders’ deficit increased from $3,232,026 as of February 28, 2019 to $3,456,793 as of November 30, 2019.

 
5
 
Table of Contents

Nine Month Period Ended November 30, 2017 Compared to Nine Month Period Ended November 30, 2016

Total Revenue.We did not generate any revenue during the nine month periods ended November 30, 2017 or November 30, 2016.

Operating expenses. During the nine month period ended November 30, 2017, we incurred operating expenses in the amount of $1,644,983 compared to operating expenses incurred during the nine month period ended November 30, 2016 of $30,089,716 (a decrease of $28,444,733). Operating expenses include: (i) general and administrative of $300,818 (2016: $290,323); (ii) research and development expenses of $599,766 (2016: $778,582); and (iii) stock based compensation of $744,399 (2016: $29,020,811). General and administrative expenses increased by $10,495 mainly due to an increase in professional fees. Research and development expenses decreased by $178,816 based on streamlining the services and scope of work of existing consultants. Stock based compensation also decreased by $28,276,412 mainly relating to (a) the fair value of $38,694,414 for which a charge for the nine months ended November 30, 2016 was $29,020,811 pertaining to the issuance of 1,000,000 shares of Series A Preferred Stock to Richard Hue, our President/Chief Executive Officer; and (b) the valuation of the grant of 5,606,500 stock options resulting in $744,399 expensed during the nine month period ended November 30, 2017.

Net Loss.Our net loss for the nine month period ended November 30, 2017 was $1,644,983 compared to a net loss of $30,089,716 during the nine month period ended November 30, 2016 (a decrease in net loss of $28,444,733). We did not generate any revenue during the nine month periods ended November 30, 2017 and November 30, 2016, respectively.

Translation Adjustment.During the nine month period ended November 30, 2017, we incurred a translation adjustment of ($104,305) compared to ($18,539) incurred during the nine month period ended November 30, 2016 representing change in the foreign exchange rate as a result of translating transaction and balances of Canadian based subsidiary.

Comprehensive income (loss). Thus, this resulted in comprehensive loss of ($1,540,678) or ($0.013) per share for the nine month period ended November 30, 2017 compared to a comprehensive loss of ($30,071,177) or ($0.251) per share for the nine month period ended November 30, 2016. The weighted average number of shares outstanding was 120,909,775 for nine month periods ended November 30, 2017 compared to 120,000,000 for nine months period ended November 30, 2016.

Three Month Period Ended November 30, 2017 Compared to Three Month Period Ended November 30, 2016

Total Revenue.We did not generate any revenue during the three month periods ended November 30, 2017 or November 30, 2016.

Operating expenses. During the three month period ended November 30, 2017, we incurred operating expenses in the amount of $420,375 compared to operating expenses incurred during the three month period ended November 30, 2016 of $10,069,929 (a decrease of $9,649,554). Operating expenses include: (i) general and administrative of $118,262 (2016: $77,895); (ii) research and development expenses of $146,684 (2016: $318,430); and (iii) stock based compensation of $155,429 (2016: $9,673,604). General and administrative expenses increased by $40,367 mainly due to an increase in professional fees. Research and development expenses decreased by $171,746 based on streamlining the services and scope of work of existing consultants. Stock based compensation also decreased by $9,518,175 relating to: (a) the fair value of $38,694,414 for which a charge for the three months ended November 30, 2016 was $ 9,673,604 pertaining to the issuance of 1,000,000 shares of Series A preferred stock to Richard Hue, our President/Chief Executive Officer; and (ii) the valuation of the grant of 5,606,500 stock options resulting in $155,429 expensed during the three month period ended November 30, 2017.

Net Loss.Thus, during the three month period ended November 30, 2017, this resulted in a net loss of ($420,375) compared to a net loss of ($10,069,929) for the three month period ended November 30, 2016.

Translation Adjustment.During the three month period ended November 30, 2017, we incurred a translation adjustment of $79,679 compared to ($21,478) incurred during the three month period ended November 30, 2016 representing change in the foreign exchange rate as a result of translating transaction and balances of Canadian based subsidiary.

Comprehensive loss. Thus, this resulted in comprehensive loss of $500,054 or $0.004 per share for the three month period ended November 30, 2017 compared to a comprehensive loss of $10,048,451 or $0.084 per share for the three month period ended November 30, 2016. The weighted average number of shares outstanding was 122,749,321 for three month periods ended November 30, 2017 compared to 120,000,000 for three month period ended November 30, 2016.

6
Table of Contents

Liquidity and Capital Resources

Nine Month Period Ended November 30, 2017

As at the nine month period ended November 30, 2017, our current assets were $184,873 and our current liabilities were $2,930,553, which resulted in a working capital deficit of $2,745,680. As at the nine month period ended November 30, 2017, current assets were comprised of: (i) $153,082 in cash; and (ii) $31,791 in prepaid and other receivables. As at the nine month period ended November 30, 2017, current liabilities were comprised of: (i) $26,683 in accounts payable; (ii) $28,083 in accrued liabilities; (iii) $2,046,526 in loans payable; (iv) $174,904 due to related parties; and (v) $654,357 due to shareholder.

As of the nine month period ended November 30, 2017, our total assets were $221,882 comprised of: (i) current assets of $184,873; and (ii) equipment, net of depreciation of $37,009. The increase in total assets during the nine month period ended November 30, 2017 from fiscal year ended February 28, 2017 was primarily due to an increase in cash of $120,404.

As of the nine month period ended November 30, 2017, our total liabilities were $2,930,553 comprised of current liabilities. The increase of $258,995 in total liabilities during the nine month period ended November 30, 2017 from fiscal year ended February 28, 2017 was primarily due to an increase in loans payable of $223,573, accounts payable of $4,358 and amounts due to a shareholder of $85,810 offset by a decrease in accrued liabilities of $50,744 and due to related party of $4,002.

Stockholders’ deficit increased from ($2,576,944) for fiscal year ended February 28, 2017 to ($2,708,671) for the nine month period ended November 30, 2017.

 

Cash Flows from Operating Activities

 

We have generated negative cash flows from operating activities. For the nine month periodmonths ended November 30, 2017,2019, net cash flows used in operating activities was ($942,751)$526,163 compared to ($1,046,566)$849,529 for the nine month periodmonths ended November 30, 2016. Net cash flows used in operating activities consisted primarily of net loss of ($1,644,983) (2016: $30,089,716), which was adjusted by stock based compensation of $744,399 (2016: $29,020,811) and depreciation of $17,780 (2016: $7,963). Net cash flows used in operating activities was further changed by: (i) an increase of $11,105 (2016: ($2,641)) in prepaid expenses and other receivables; (ii) an increase of $3,836 (2016: $20,841) in accounts payable; and (iii) a decrease of ($52,678) (2016: ($3,824)) in accrued liabilities.2018.

 

Cash Flows from Investing Activities

For the nine month period ended November 30, 2017, we used cash of $11,998 (2016: $14,486) in investing activities, which consisted of purchase of equipment.

Cash Flows From Financing Activities

 

Net cash flows provided from financing activities during the nine month periodmonths ended November 30, 20172019 was $1,100,441,$639,907, which consisted of: (i) $873,163of $364,907 in proceeds from loans and $275,000 in proceeds from the issuance of shares; (ii) $166,687 in loans payable; and (iii) $69,552 due to a shareholder, which was offset by ($8,961) due to a related party.common stock. During the nine month periodmonths ended November 30, 2016,2018, cash flows provided by financing activities was $1,064,424,$835,492, which consisted of $951,666 in$625,000 from the issuance of shares and $215,938 from the proceeds of loans, payable and $159,792 due to a shareholder, which was offset by ($47,034) due to related parties.$5,446 in repayments of loans payable.

 

Material Commitments

 

The balancesbalance due to related parties and shareholder areparty is interest free, unsecured and are repayable on demand. The balancesbalance due to a related parties and shareholders areparty is mainly in connection with the services and financing provided for the development of an online complaint resolution platform.

 

On October 7, 2019, the Company entered into an agreement with a company who is to provide general financial advisory and investment banking services to the Company. The Company is to pay this company $5,000 per month for a period of six months. The monthly fee can be paid in cash or in shares at the Company’s option. If paid in shares of common stock of the Company, the shares shall be valued using the volume-weighted average price of the shares for the five trading days immediately preceding each monthly fee payment due date. The Company is to issue 2,500,000 shares of common of stock upon execution of the agreement (issued) and 2,500,000 shares of common stock upon an uplisting of the Company’s common stock to a national exchange. For any financing, the Company will pay this company a commission of 8% of financing raised, a cash fee for unallocated expenses of 1% of the amount of financing raised, and issue agent’s warrants equal to 8% of the number of shares of common stock underlying the securities issued in the financing. Each agent’s warrant will be exercisable at an exercise price equal to the price of the securities issued to the investors in the financing expiring five years from the date of issuance.

Off-Balance Sheet Arrangements

 

There were no off-balance sheet arrangements during the nine month periodmonths ended November 30, 20172019 that have, or are reasonably likely to have, a current or future effect on our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our interests.

 
7
Table of Contents

Plan of Operation

 

As at November 30, 2017,2019, we had an accumulateda working capital deficit of $48,279,952$3,477,078 and we will require additional financing in order to enable us to proceed with our plan of operations. When we will require additional financing, thereThere can be no assurance that additional financing will be available to us or that it can be obtained on commercially reasonable terms. If we are not able to obtain the additional financing on a timely basis, we will not be able to meet our other obligations as they become due. We are pursuing various alternatives to meet our immediate and long-term financial requirements.

 

We anticipate continuing to rely on equity sales of our common stock and loans in order to fund our business operations. Issuances of additional shares will result in dilution to existing stockholders. There is no assurance that we will achieve any additional sales of equity securities or arrange for debt or other financing to fund our planned business activities.

 

6
Table of Contents

Our auditor has issued a going concern opinion.opinion on our financial statements for the fiscal year ended February 28, 2019. Additionally, at November 30, 2019, the Company has a working capital deficit of $3,477,078, and has an accumulated deficit of $54,149,162 since inception. Furthermore, during the nine months ended November 30, 2019, the Company used $526,163 in operating activities. This means that there is substantial doubt that we can continue as an on-going business for the next twelve months unless we generate sufficient revenues. There is no assurance we will ever reach that point. In the meantime, the continuation of the Company is dependent upon the continued financial support from our shareholders, our ability to obtain necessary equity financing to continue operations and the attainment of profitable operations.

 

Our operations and financial results are subject to various risks and uncertainties that could adversely affect our business, financial condition and results of operations.

 

We require approximately $150,000$1,500,000 for the next 12 months as a reporting issuer and additional funds are required. Before generation of revenue, the additional funding may come from equity financing from the sale of our common stock or loans from management or related third parties. In the event we do not raise sufficient capital to implement its planned operations or divest, your entire investment could be lost.

 

We have not paid any sums for public relations or investor relations.

 

Recent Accounting Pronouncements

 

Please seeAs reflected in Note 4 — “Recent Accounting Standards”2 of the Notes to the Condensed Consolidated Financial Statements, for a discussion of the effects of recently issued accounting pronouncements.

Critical Accounting Policies

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States. To apply these principles, we must make estimates and judgments that affect our reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities. In many instances, we reasonably could have used different accounting estimates and, in other instances, changes in the accounting estimates are reasonably likely to occur from period to period. Accordingly, actual results could differ significantly from our estimates. To the extent that there are material differences between these estimates and actual results, our financial condition or results of operations will be affected. We base our estimates and judgments on historical experience and other assumptions that we believe to be reasonable at the time and under the circumstances, and we evaluate these estimates and judgments on an ongoing basis. We refer to accounting estimates and judgments of this type as critical accounting policies, judgments, and estimates. Management believes there have been no materialrecent accounting pronouncements or changes duringin accounting pronouncements that impacted the threenine months ended November 30, 20172019 or which are expected to impact future periods as follows:

In February 2016, the criticalFASB issued new lease accounting policies reportedguidance in “Management’s DiscussionASU No. 2016-02, “Leases”. This new guidance was initiated as a joint project with the International Accounting Standards Board to simplify lease accounting and Analysisimprove the quality of Financial Condition and Resultscomparability of Operations” in our Annual Report on Form 10-Kfinancial information for users. This new guidance would eliminate the concept of off-balance sheet treatment for “operating leases” for lessees for the vast majority of lease contracts. Under ASU No. 2016-02, at inception, a lessee must classify all leases with a term of over one year as either finance or operating, with both classifications resulting in the recognition of a defined “right-of-use” asset and a lease liability on the balance sheet. However, recognition in the income statement will differ depending on the lease classification, with finance leases recognizing the amortization of the right-of-use asset separate from the interest on the lease liability and operating leases recognizing a single total lease expense. Lessor accounting under ASU No. 2016-02 would be substantially unchanged from the previous lease requirements under GAAP. ASU No. 2016-02 will take effect for public companies in fiscal year ended February 28, 2017.years beginning after December 15, 2018, including interim periods within those fiscal years. Early adoption is permitted and for leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, lessees and lessors must apply a modified retrospective transition approach. The Company is currently evaluating the new guidance and has not determined the impact this standard may have on the consolidated financial statements.

 

In August 2018, the FASB issued ASU 2018-13, “Changes to Disclosure Requirements for Fair Value Measurements”, which will improve the effectiveness of disclosure requirements for recurring and nonrecurring fair value measurements. The standard removes, modifies, and adds certain disclosure requirements, and is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. The Company will be evaluating the impact this standard will have on the Company’s financial statements.

The Company has implemented all new accounting pronouncements that are in effect and that may impact its consolidated financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations. 

 
87
 
Table of Contents

  

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Disclosure Controls and Procedures

 

Pursuant to Rule 13a-15(b)We have carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer/Principal Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, (“Exchangeas amended (the “Exchange Act”),) as of November 30, 2019. Based on such evaluation, we have concluded that, as of such date and for the Company carried out an evaluation, with the participation of the Company’s management, including the Company’s Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”) (the Company’s principal financial and accounting officer), of the effectiveness of the Company’sreason described below, our disclosure controls and procedures (as defined under Rule 13a-15(e) under the Exchange Act) as of the end of the period covered by this report. Based upon that evaluation, the Company’s CEO and CFO concluded that the Company’s disclosure controls and procedures arewere not effective as of November 30, 2017 to ensure that information required to be disclosed by the Companyus in the reports that the Company files or submits under theour Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC’sapplicable SEC rules and forms, and that such information is accumulated and communicated to the Company’sour management, including the Company’s CEO and CFO,our Chief Executive Officer/Principal Financial Officer, as appropriate, to allow timely decisionsdiscussions regarding required disclosure for the reason described below.disclosure.

 

Because of our limited operations, we have a limited number of employees which prohibits a segregation of duties. In addition, we lack a formal audit committee with a financial expert. As we grow and expand our operations we will engage additional employees and experts as needed. However, there can be no assurance that our operations will expand.

 

Changes in Internal Control Over Financial Reporting

 

There were no changes in our internal control over financial reporting that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

 
98
 
Table of Contents

 

PART II - OTHER INFORMATION

 

ITEM 1.1. LEGAL PROCEEDINGS

 

The Company currently is not a party to any legal proceedings and, to the Company’s knowledge; no such proceedings are threatened or contemplated.

 

ITEM 1A.1A. RISK FACTORS

 

Not applicable.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

Consulting Agreements

During December 2017, our Board of Directors (the “Board”) approved to issue an aggregate of 5,674,944the three months ended November 30, 2019, we issued shares of our restricted common stock to certain consultants (the “Consultants”) in consideration of various services rendered to the Company. As of the date of this Quarterly Report, these shares are not issued. The shares of restricted common stock are to be issued to the Consultants in reliance on the exemption from registration under by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”).follows:

 

Private Placement

During the nine month period ended November 30, 2017 and to current date, we have engaged in private placements offerings of our shares of restricted common stock in reliance on Regulation S promulgated under the Securities Act.

During the nine month period ended November 30, 2017 pursuant to subscription agreements (“Subscription Agreements”), we sold an aggregate 2,494,750 shares of our restricted common stock in a private placement offering to certain non-U.S. investors at a price of $0.35 per share of common stock and received gross proceeds of $873,163. On December 15, 2017, the Board approved to issue an aggregate of 2,494,750 shares of common stock to the investors. As of the date of this Quarterly Report, these shares are not issued.

The foregoing description of the Subscription Agreement is not complete and is qualified in its entirety by reference to the full text of the Subscription Agreement, a form of which is filed as Exhibit 10.1 hereto and is incorporated by reference herein.

·4,500,000 shares were sold to 3 parties at $0.05 per share for proceeds of $225,000.

·2,500,000 shares were issued to a company which will be providing financial advisory and investment banking services to the Company.

·1,500,000 shares were issued in connection with an agreement to settle $75,000 of debt. The shares were fair valued at $96,000, based on the market price on the date of settlement.

·2,000,000 shares were issued in connection with an agreement to settle $100,000 of debt. The shares were fair valued at $128,000, based on the market price on the date of settlement.

 

The securities referenced above were issued in reliance on the exemption from registration affordafforded by Regulation S promulgated under the Securities Act as a transaction by an issuer not involving a public offering.Act. Such shares of common stock havewill not beenbe registered under the Securities Act or under any state securities laws and may not be offered or sold without registration with the United States Securities and Exchange Commission or an applicable exemption from the registration requirements. The investors acknowledgedare acknowledging that the securities to be issued have not been registered under the Securities Act, that they understoodunderstand the economic risk of an investment in the securities, and that they have had the opportunity to ask questions of and receive answers from our management concerning any and all matters related to acquisition of the securities.

 
10
Table of Contents

Grant of Options

On November 27, 2017, the Board granted Ms. Helen Bernardino an option to purchase 120,000 shares of common stock of the Company, par value $0.001, at an exercise price of $0.20 per share, in connection with Ms. Bernardino’s appointment as a director of the Company. Such option shall have a term of five (5) years and vested immediately upon the effective date of her appointment, November 27, 2017. The securities were issued in reliance on the exemption from registration under by Section 4(a)(2) of the Securities Act.

Except as set forth in this Item 2, there were no unregistered securities sold by us during the quarter ended November 30, 20172019 that were not otherwise disclosed in a Current Report on Form 8-K.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

See Part II, Item 2 of this Form 10-Q None.

 

 
119
 
Table of Contents

  

ITEM 6. EXHIBITS

 

The following exhibits are filed as part of this Form 10-Q:

Exhibit No.

Number

 

Description

2.1

Share Exchange Agreement by and among Resolution 1, Inc., the stockholders of ExhibitsResolution 1, Inc., and flooidCX Corp. dated May 17, 2019 incorporated herewith as filed as an Exhibit to the Current Report on Form 8-K on May 21, 2019.

3. 1

Articles of Incorporation of Baixo Relocation Services Inc. incorporated herewith as filed as an Exhibit to the Registration Statement on Form S-1 on June 11, 2014.

3.1.2

Amendment to Articles of Incorporation of Baixo Relocation Services Inc. incorporated herewith as filed as an Exhibit to the Current Report on Form 8-K on December 29, 2016.

3.1.3

Designation of Series A Preferred Stock filed with the Nevada Secretary of State on April 20, 2017 incorporated herewith as filed as an Exhibit to the Form 8-K on May 9, 2017.

3.1.4

Certificate of Amendment to Articles of Incorporation incorporated herewith as filed as an Exhibit to the Current Report on Form 8-K on March 21, 2019.

3.2

Bylaws of Baixo Relocation Services Inc. incorporated herewith as filed as an Exhibit to the Registration Statement on Form S-1 on June 11, 2014.

4.1

Form of Share Purchase Warrant dated December 1, 2016 incorporated herewith as filed as an Exhibit to the Current Report on Form 8-K on January 13, 2017.

 

10.1

 

SubscriptionLease Agreement between Katalex Holdings Inc. and MBE Holdings Inc. dated December 6, 2016 incorporated herewith as filed as an Exhibit to the Company and non-U.S. investors+Form 8-K on March 3, 2017.

10.2

Gripevine Inc. 2017 Flexible Stock Plan dated August 16, 2017 incorporated herewith as filed as an Exhibit to the Form 8-K on October 3, 2017.

10.3

Debt Settlement Agreement dated November 4, 2019 filed herewith.

10.4

Debt Settlement Agreement dated November 4, 2019 filed herewith.

31.1

 

Section 302 Certification of Principal Executive Officer+Officer pursuant to 18 U.S.C.§ 1350, as adopted pursuant to § 302 of the Sarbanes-Oxley Act of 2002.

31.2

 

Section 302 Certification of Principal Financial Officer+

32.1

 

Section 906 Certification of Principal Executive Officer+Officer and Principal Financial Officer pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002.

101.INS

101**

 

XBRL Instance Document +Interactive data files pursuant to Rule 405 of Regulation S-T.

____________

101.SCH

**

XBRL Taxonomy Extension Schema Document +

101.CAL

XBRL Taxonomy Calculation Linkbase Document +

101.LAB

XBRL Taxonomy Labels Linkbase Document +

101.PRE

XBRL Taxonomy Presentation Linkbase Document +

101.DEF

XBRL Definition Linkbase Document +(Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

___________

+filed herewith

 

 
1210
 
Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Reportreport to be signed on its behalf by the undersigned, thereunto duly authorized.

 

GRIPVINE INC.flooidCX Corp.

 

January 16, 201817, 2020

By:

/s/ Richard Hue

 

Richard Hue

 

Chief Executive Officer, President, Secretary, Treasurer, Chief Financial Officer and Director

  

1311